Antimicrobial peptides (AMPs) have been shown to exhibit cytotoxic effects against various cancer cell lines (Tornesello et al., 2020), including breast cancer, lung cancer, melanoma, leukemia, and lymphoma. This evidence concerns the gene ADSL and melanoma.